Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications

Loscos, Jordi; Valldeperas, Xavier; Langhor, Klaus; Parera, Àngels; Romera, Pau; Sabala, A.; Cámara, J. de la

doi:10.1007/s10792-015-0037-y

Cited by 9 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[5] Sanchez et al 1996. [6] Loscos J et al [7] Loscos-Arenas J et al [8] Greifner G et al [9] and most others indicate that the preoperative IOP taken for our study falls in the same range as that taken in other similar studies. Also the average age range in our study vs similar studies and within the three groups in our study are statistically insignificant.…”

Section: Resultssupporting

confidence: 70%

Comparative Analysis of Penetrating and Non-Penetrating Glaucoma Surgery in Primary Open Angle Glaucoma

Pendke¹,

Bhalgat²

2016

jemds

View full text Add to dashboard Cite

OBJECTIVESPurpose analysis of safety and efficacy of Non-Penetrating Glaucoma Surgery (NPGS) for control and maintenance of intraocular pressure as compared to penetrating glaucoma surgery in Primary Open Angle Glaucoma (POAG) patients. DESIGNA hospital based randomized study. Participants 70, eyes of 70 POAG patients, 35 of which underwent NPGS and the remaining underwent Trabeculectomy surgery. MATERIALSNPGS and trabeculectomy was performed by standard surgical procedures after recording routine preoperative data. Patients were divided into 2 groups depending on the procedure they underwent. All patients were followed up after 1 week, 1 month, 3 months, 6 months and 12 months. Post-operative success was defined as IOP <21 mmHg at 1 month in absence of additional antiglaucoma medication or other treatment. RESULTSA significant reduction in intraocular pressure was observed post-surgery in both groups, changing from a preoperative mean of 31.09±7.37 mmHg and 29.26±7.10 mmHg to a postoperative mean of 15±3.06 mmHg and 14.85±4.22 mmHg respectively (P<0.001) at 12 months for trabeculectomy patients. It was seen that there was approximately constant reduction in all ranges of IOP, while for NPGS patient's best control in IOP was seen between at preoperative IOP between 21 to 30 mmHg. There was a significant difference in complications between two groups and the NPGS group had significantly less number of complications than the trabeculectomy group (p<0.05). However, the trabeculectomy group had a significantly lesser failure rate as compared to the NPGS group (p<0.05). CONCLUSIONTrabeculectomy though more effective for higher preoperative IOP, range is associated with greater risk of complications and hence for IOP range between 21 to 30 mmHg, NPGS would be the surgery of choice due to its equivalent efficacy and much greater safety standards.

show abstract

Section: Resultssupporting

confidence: 70%

Comparative Analysis of Penetrating and Non-Penetrating Glaucoma Surgery in Primary Open Angle Glaucoma

Pendke¹,

Bhalgat²

2016

jemds

View full text Add to dashboard Cite

show abstract

“…28 Hypotony was observed in 3% of our cohort, which also compares favourably with the hypotonyrate of 7.2% reported by the aforementioned paper by Kirwan et al 25 Over a mean follow-up period of 63.5 months (in 296 eyes), we only observed three serious complications related to hypotony: two eyes required resuturing, whereas one resulted in delayed LGP is considered an important adjunct to DS in achieving low target IOPs. Reported rates vary from 36 to 67% 19,[28][29][30][31] The overall rate of LGP in our cohort was 54.4%. Patients in the phaco-DS with MMC group had a significantly greater chance of undergoing LGP (75.7%) compared with the unaugmented phaco-DS group (51.4%) at 5 years after surgery (P = 0.05).…”

Section: Discussionmentioning

confidence: 66%

Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study

Mercieca

Shevade

Anand

2015

Eye

View full text Add to dashboard Cite

Purpose To report the outcomes of combined phacoemulsification and -deep sclerectomy (phaco-DS) from a single UK centre over a 10-year period. Methods Retrospective analysis of phaco-DS data extracted from an ongoing glaucoma surgery database within Calderdale and Huddersfield NHS Trust. Two hundred and ninety-six eyes of 282 patients were included. Data included patient demographics, pre-and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates. IOP success criteria were: (A) IOP o19 mm Hg and/or 20% decrease from baseline and (B) IOP o16 mm Hg and/or 30% drop from baseline. Results Mean follow-up was 63.5 ± 35.3 months. MMC was applied in 145 eyes (49%). Kaplan-Meier success rates in all eyes for criteria A were 89.1% and 80% with glaucoma medications (qualified success) and 81.2% and 68.3% without medications (unqualified success) at 2 and 5 years, respectively. Qualified success for criteria B was 72.4 and 61.4% and unqualified rates were 67.2 and 55.2% for the same time periods. Repeatedmeasures ANOVA showed significantly lower IOP in the phaco-DS with MMC group up to 3 years postoperatively (P = 0.002). Cox's proportional hazards for criteria B, however, showed no significant effect of MMC application in the long term (P = 0.2). Increasing age and laser goniopuncture were positively associated with success, whereas the absence of spacer devices was negatively associated. At last follow-up, 20% of eyes were on glaucoma medications. Complication rates were low with hypotony rates of 0.68%. Conclusions This study confirms the longterm safety and efficacy of phaco-DS as a primary glaucoma procedure.

show abstract

“…MINIject, our study 3.2 Single iStent [10] 5.4 Dual iStent [10] 5.3-11.8 CyPass + Phako [10] 8.1 Hydrus [10] 6.6 Trabectome [10] 4.6-9.7 XEN [11] 10.1-10.4 Preserflo [12] 6.8 Trebeculectomy [12] 10.0 Solx Gold [13] 9.0 Esnoper V 2000 [14] 8.1 Esnoper Clip [15] 9.0 2× iStent, 1× iStent Supra, Prostaglandin [16] 8.3…”

Section: Intervention Iop-reduction [Mmhg]mentioning

confidence: 98%

Clinical Results of the MINIject Implant for Suprachoroidal Drainage

Gläser,

Böhringer,

Evers

et al. 2024

JCM

View full text Add to dashboard Cite

Objective: This retrospective study evaluated the safety and efficacy of the new minimally invasive MINIject implant placed in the suprachoroidal space. The aim was to assess its impact on intraocular pressure (IOP) reduction and complication rate. Methods: 18 eyes from 18 patients with insufficiently controlled glaucoma received the implant using topical medications. Outcomes were changes in IOP, change in IOP medication, need for other glaucoma surgery, and rate of adverse events. Results: IOP reduced by 15% (p < 0.05) following MINIject implantation. IOP medication decreased from 3 to 1 agent (p < 0.05). Four patients (22%) required other glaucoma surgery while we did not observe any clinically relevant adverse event. Conclusions: This retrospective study indicates that MINIject implants may be a safe and effective means of reducing IOP together with a reduction in IOP medications in most patients. Larger prospective studies with longer follow-ups are necessary to confirm our results, though.

show abstract

Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications

Cited by 9 publications

References 12 publications

Comparative Analysis of Penetrating and Non-Penetrating Glaucoma Surgery in Primary Open Angle Glaucoma

Comparative Analysis of Penetrating and Non-Penetrating Glaucoma Surgery in Primary Open Angle Glaucoma

Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study

Clinical Results of the MINIject Implant for Suprachoroidal Drainage

Contact Info

Product

Resources

About